1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Pembrolizumab–vibostolimab for untreated metastatic non-small-cell lung cancer [ID6365]

Awaiting development [GID-TA11442] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 34689-Pembrolizumab-Vibostolimab-and-Chemotherapy-for-Small-Cell-Lung-Cancer-V1.0-JUL2023-NON-CONF.pdf (nihr.ac.uk)